These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36726477)

  • 81. Distinct effects of IPSU and suvorexant on mouse sleep architecture.
    Hoyer D; Dürst T; Fendt M; Jacobson LH; Betschart C; Hintermann S; Behnke D; Cotesta S; Laue G; Ofner S; Legangneux E; Gee CE
    Front Neurosci; 2013; 7():235. PubMed ID: 24368893
    [TBL] [Abstract][Full Text] [Related]  

  • 82. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.
    Vermeeren A; Vets E; Vuurman EF; Van Oers AC; Jongen S; Laethem T; Heirman I; Bautmans A; Palcza J; Li X; Troyer MD; Wrishko R; McCrea J; Sun H
    Psychopharmacology (Berl); 2016 Sep; 233(18):3341-51. PubMed ID: 27424295
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Real-world evidence of the safety and efficacy profile of suvorexant in elderly patients with insomnia: a sub-analysis of the post-marketing drug-use results survey in Japan.
    Takeuchi Y; Sano H; Asai Y; Miyazaki M; Iwakura M; Maeda Y
    Curr Med Res Opin; 2020 Mar; 36(3):465-471. PubMed ID: 31793350
    [No Abstract]   [Full Text] [Related]  

  • 84. Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep Disorders.
    Carpi M; Mercuri NB; Liguori C
    Drugs; 2024 Oct; ():. PubMed ID: 39365407
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Treatment of sleep-related eating disorder with suvorexant: A case report on the potential benefits of replacing benzodiazepines with orexin receptor antagonists.
    Matsui K; Kimura A; Nagao K; Yoshiike T; Kuriyama K
    PCN Rep; 2023 Sep; 2(3):e123. PubMed ID: 38867814
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review.
    Sys J; Van Cleynenbreugel S; Deschodt M; Van der Linden L; Tournoy J
    Eur J Clin Pharmacol; 2020 Mar; 76(3):363-381. PubMed ID: 31838549
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs.
    Kumar A; Chanana P; Choudhary S
    Pharmacol Rep; 2016 Apr; 68(2):231-42. PubMed ID: 26922522
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Therapy for Insomnia and Circadian Rhythm Disorder in Alzheimer Disease.
    Ferini-Strambi L; Galbiati A; Casoni F; Salsone M
    Curr Treat Options Neurol; 2020 Feb; 22(2):4. PubMed ID: 32025925
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Dual orexin receptor blocker suvorexant attenuates hypercapnic ventilatory augmentation in mice.
    Fukushi I; Yokota S; Takeda K; Terada J; Umeda A; Yoshizawa M; Kono Y; Hasebe Y; Onimaru H; Pokorski M; Okada Y
    Brain Res; 2022 Nov; 1795():148061. PubMed ID: 36037880
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prompt improvement of difficulty with sleep initiation and waking up in the morning and daytime somnolence by combination therapy of suvorexant and ramelteon in delayed sleep-wake phase disorder: a case series of three patients.
    Izuhara M; Kawano K; Otsuki K; Hashioka S; Inagaki M
    Sleep Med; 2021 Apr; 80():100-104. PubMed ID: 33588260
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Preclinical and clinical efficacy of orexin receptor antagonist Lemborexant (Dayvigo
    Koebisu M; Koyama N; Nishida M; Muramoto K
    Nihon Yakurigaku Zasshi; 2021; 156(2):114-119. PubMed ID: 33642529
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Emerging and upcoming therapies in insomnia.
    Kim WJ; Kim HS
    Transl Clin Pharmacol; 2024 Mar; 32(1):1-17. PubMed ID: 38586124
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Lack of Efficacy of Suvorexant in People with Insomnia and Poorly Controlled Type 2 Diabetes.
    Winkelman JW; Wipper B; Zackon J; Hoeppner BB
    Nat Sci Sleep; 2023; 15():1117-1128. PubMed ID: 38152441
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
    Campbell EJ; Marchant NJ; Lawrence AJ
    Brain Res; 2020 Mar; 1731():145902. PubMed ID: 30081035
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status.
    Mieda M; Sakurai T
    CNS Drugs; 2013 Feb; 27(2):83-90. PubMed ID: 23359095
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pharmacodynamic effects of suvorexant and zolpidem on EEG during sleep in healthy subjects.
    Struyk A; Gargano C; Drexel M; Stoch SA; Svetnik V; Ma J; Mayleben D
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1649-56. PubMed ID: 27554636
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effect of suvorexant on nighttime blood pressure in hypertensive patients with insomnia: The SUPER-1 study.
    Kario K; Yamasaki K; Yagi K; Tsukamoto M; Yamazaki S; Okawara Y; Tomitani N; Kanegae H
    J Clin Hypertens (Greenwich); 2019 Jul; 21(7):896-903. PubMed ID: 30874378
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study.
    Hatano M; Kamei H; Inagaki R; Matsuzaki H; Hanya M; Yamada S; Iwata N
    Clin Psychopharmacol Neurosci; 2018 May; 16(2):184-189. PubMed ID: 29739132
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Comparative efficacy and safety of suvorexant and lemborexant for insomnia treatment.
    Hayashi T; Yamanashi T; Iwata M
    PCN Rep; 2023 Mar; 2(1):e85. PubMed ID: 38868407
    [TBL] [Abstract][Full Text] [Related]  

  • 100. An update of management of insomnia in patients with chronic orofacial pain.
    Almoznino G; Haviv Y; Sharav Y; Benoliel R
    Oral Dis; 2017 Nov; 23(8):1043-1051. PubMed ID: 28075519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.